Skip to main content
Vil du afgive tilbud på offentlige udbud? Se vores TaaS-service til forberedelse af udbud
Udbud

Insulinpumper, kontinuerlige glukoseovervågningsprodukter, der bidrager til levering af hybrid lukkede kredsløbsveje og tilhørende produkter

Åben
Frist
79 dage tilbage
Juni 22, 2026
Kontrakt detaljer
Kategori
Andet
Reference
011652-2026
Værdi
£3,600,000,000
Lokation
United Kingdom, Storbritannien
Udgivet
Marts 27, 2026
CPV-kode
Projekttidslinje

Udbud offentliggjort

Februar 10, 2026

Frist for spørgsmål

Juni 15, 2026

Frist for tilbud

Juni 22, 2026

Kontraktens startdato

Maj 31, 2027

OrdregiverindsigtPRO
🔒
Lås op for ordregiverindsigt
Se forbrugsmønstre, foretrukne procedurer og mere.
Opgrader til Professionel →
Budget
£3,600,000,000
Varighed
96 måneder
Lokation
United Kingdom
Type
Andet
75
Kvalitetsscore/100
God

Original udbudsbeskrivelse

NHS Supply Chain understøtter nationale diabetesydelser ved at muliggøre retfærdig adgang til avancerede diabetesteknologier, opmuntre til åbenhed over for innovation og sikre en passende balance mellem kliniske resultater, cybersikkerhed, interoperabilitet og værdi for pengene. Denne meddelelse offentliggøres for at informere markedet og invitere leverandører til at deltage i foreløbig markedsengagement i overensstemmelse med Procurement Act 2023. NHS Supply Chain undersøger den potentielle etablering af en åben rammeaftale med en foreslået varighed på op til otte (8) år for levering af insulinpumper, kontinuerlige glukoseovervågningsprodukter (CGM), komponenter til hybrid lukkede kredsløbssystemer og tilhørende produkter og tjenester. Det foreslåede omfang kan omfatte, men er ikke begrænset til, tilsluttede insulinpumper, plasterinsulinpumper, kontinuerlige glukoseovervågningsenheder, produkter, der bidrager til funktionaliteten af hybrid lukkede kredsløbs insulindoseringssystemer, forbrugsstoffer og smarte insulinpenne. Præcise mængder er ukendte. Det forventes, at de vejledende udgifter i det første år kan ligge i størrelsesordenen £240.000.000 til £250.000.000 GBP (eksklusive moms). Dette estimat er kun vejledende og kan variere afhængigt af de kontraherende myndigheders krav, der får adgang til rammeaftalen. Den estimerede samlede værdi over den potentielle otteårige varighed er ca. £3.000.000.000 GBP (eksklusive moms). Enhver fremtidig rammeaftale vil understøtte leveringen af NHS Englands Implementeringsplan i henhold til National Institute for Health and Care Excellence (NICE) Technology Appraisal TA943 – Hybrid lukkede kredsløbssystemer til håndtering af blodsukkerniveauer ved type 1-diabetes, offentliggjort den 19. december 2023. Deltagelse i dette foreløbige markedsengagement er frivilligt og udgør ikke en forpligtelse fra NHS Supply Chain til at påbegynde et udbud, tildele en kontrakt eller inkludere nogen deltager i en fremtidig udbudsproces. Ethvert fremtidigt udbud vil blive gennemført i overensstemmelse med Procurement Act 2023 og offentliggjort via Find a Tender Service efter behov. Enhver resulterende rammeaftale vil blive indgået mellem NHS Supply Chain og den/de udpegede leverandør(er).

Risikoanalyse

Risikoanalyse er endnu ikke tilgængelig for dette lands udbud. Understøttede lande i øjeblikket: Estland, Polen, Litauen og Letland.

Vinderstrategi

Få en AI-drevet vinderstrategi skræddersyet til dette udbud. Inkluderer sandsynlighedsscore for at vinde, vigtige muligheder og udfordringer, anbefalede fokusområder for tilbuddet, indsigt i konkurrencepositionering og handlingsrettede anbefalinger for at maksimere dine chancer.

Log ind

Konkurrenter

Opgrader for at se, hvilke virksomheder der sandsynligvis vil afgive tilbud på dette udbud, baseret på historiske indkøbsdata.

Log ind

Krav og kvalifikationer

18 krav på tværs af 5 kategorier

Indsendelse (3)
Obligatorisk (2)
Overholdelse (2)
Teknisk (9)
Finansiel (2)
SUBMISSION REQUIREMENTS3
--Participation in the preliminary market engagement is voluntary.
--No specific submission requirements for a tender bid are detailed in this preliminary market engagement notice.
--Future procurement will be published via the Find a Tender Service and will outline specific submission requirements.
MANDATORY EXCLUSION GROUNDS2
--No specific mandatory exclusion grounds are detailed in this preliminary market engagement notice.
--Future procurement will be conducted in accordance with the Procurement Act 2023, which will define applicable mandatory exclusion grounds.
ELIGIBILITY REQUIREMENTS2
--No specific eligibility requirements for bidding are detailed in this preliminary market engagement notice.
--Future procurement will define eligibility criteria for suppliers of advanced diabetes technologies.
TECHNICAL CAPABILITY REQUIREMENTS9
--Ability to supply insulin pumps (tethered, patch).
--Ability to supply continuous glucose monitoring (CGM) devices.
--Ability to supply hybrid closed loop system components.
FINANCIAL REQUIREMENTS2
--No specific financial requirements for bidding are detailed in this preliminary market engagement notice.
--Future procurement will likely require demonstration of financial stability and capacity to deliver a framework agreement potentially valued up to £3,000,000,000 GBP over eight years.

Forhåndsvisning af Krav

Tilmeld dig for at se komplette krav og analyser

Dokumenter

4 dokumenter tilgængelige med AI-resuméer

OCDS RecordDOC
011652-2026_ocds_record.json

Download failed - no summary available

Vis
OCDS Release PackageDOC
011652-2026_ocds_release.json

This OCDS data package provides details on NHS Supply Chain's preliminary market engagement for a potential £3 billion framework agreement for insulin pumps, continuous glucose monitoring devices, and related diabetes technologies.

Vis
Official PDF VersionPDF
011652-2026_official.pdf

NHS Supply Chain is conducting preliminary market engagement for a potential £3 billion, 8-year framework agreement for insulin pumps, continuous glucose monitoring devices, and related diabetes technologies, inviting suppliers to participate voluntarily.

Vis
Tender NoticeHTM
011652-2026.html

NHS Supply Chain is conducting preliminary market engagement for a potential 8-year framework agreement, valued up to £3 billion, for insulin pumps, continuous glucose monitoring devices, and related hybrid closed loop system components to support national diabetes services.

Vis

Forhåndsvisning af Dokumenter

Tilmeld dig for at se dokumentresuméer og analyser

75
God

Udbudskvalitetsscore

This is a well-structured preliminary market engagement notice, clearly outlining the scope and intent for a significant future framework agreement. While some formal fields are empty and full tender details are absent, this is appropriate for its 'planning' status.

Scoreopdeling

Overholdelse af lovgivning75/100

The notice explicitly states it's a preliminary market engagement in accordance with the Procurement Act 2023, indicating compliance with national regulations. The CPV code is relevant, and deadlines are reasonable for this stage. The empty 'Type' and 'Procedure' fields are formal gaps but are understood given the 'planning' status.

Formal 'Type' and 'Procedure' fields are empty.
Klarhed80/100

The description is very clear about the purpose, scope, duration, and estimated value of the potential future framework agreement. It explicitly states that specific bidding and evaluation criteria are not yet detailed, which is clear for a market engagement notice.

Absence of even high-level indicative evaluation criteria for the future tender.
Fuldstændighed70/100

Basic information, financial details, timeline, and scope are well-defined for a preliminary market engagement. The lack of full bidding requirements and evaluation criteria is expected at this stage. One document download failed, which is a minor technical issue.

One document download failed.
Specific bidding requirements and evaluation criteria are not yet defined (though stated as such).
Retfærdighed85/100

The notice appears fair, with broad, generic technical requirements and a disclosed value. The ample time provided for market engagement and the focus on 'openness to innovation' support a fair approach. No indication of tailoring to a specific company.

No explicit e-submission mechanism mentioned for future stages.
Praktisk anvendelighed65/100

Contract start date, duration, and financing information are clearly specified. However, the lack of explicit e-submission support and direct document URLs within the provided text are practical drawbacks for a modern procurement process.

No explicit e-submission mechanism mentioned.
Document URLs not explicitly provided in the text.
Datakonsistens90/100

Key dates and financial figures are logical and consistent. The 'planning' status aligns with the absence of disputes. The empty 'Type', 'Procedure', and 'Liable Person' fields are minor formal inconsistencies.

Formal fields 'Type', 'Procedure', and 'Liable Person' are empty.
Bæredygtighed50/100

The notice explicitly encourages 'openness to innovation', which is a positive aspect. However, it lacks specific criteria related to environmental (green procurement) or social aspects.

No explicit green procurement criteria.
No explicit social criteria.

Styrker

Clear purpose as preliminary market engagement.
Detailed scope and financial estimates provided.
Explicit reference to future compliance with Procurement Act 2023.
Focus on innovation.
Reasonable timeline for market engagement.

Bekymringer

Formal fields 'Type' and 'Procedure' are empty.
Lack of explicit green or social procurement criteria.
One document download failed.
No explicit e-submission mechanism mentioned for future stages.
Absence of even high-level indicative evaluation criteria for the future tender.

Anbefalinger

1. For the future full tender, ensure all formal fields (Type, Procedure) are populated.
2. Consider incorporating explicit green and social procurement criteria in the future tender.
3. Ensure all documents are accessible and provide clear links for e-submission.

Forhåndsvisning af AI-scoring

Tilmeld dig for at se komplette krav og analyser

Komplet analyse af kvalitetsscore
Detaljeret opdeling af underscores
Indsigter i styrker og bekymringer
Strategiske anbefalinger

Intet kreditkort krævet • Opsætning på 2 minutter

Ny service

Vil du have os til at håndtere dette udbud?

Vores udbudseksperter forbereder alt. Det virker – du gennemgår, godkender og indsender.

~1hDin tid kun
80%+80%+
$0Forudbetaling
Se fuld sammenligning
Uden TaaSMed TaaS
40-80 timer
Forberedelsestid
~1 time
Din tid kun
15-25%
Gennemsnitlig vinderate
80%+
Vinderate
Risiko for fejl
Manuel gennemgang
Ekspert QA
Overholdelsestjek
Du gør alt
Håndter alt
Vi gør alt
End-to-end service
Lad os vinde dette udbud
Betal kun, når du vinder · 400+ virksomheder stoler på os
Eller gør det selv

Tilføj til pipeline